News articles about Fonar (NASDAQ:FONR) have trended somewhat positive on Monday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Fonar earned a daily sentiment score of 0.19 on Accern’s scale. Accern also gave media coverage about the medical equipment provider an impact score of 48.2190278531712 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
Fonar (NASDAQ:FONR) traded down $0.45 on Monday, hitting $24.00. 23,800 shares of the company were exchanged, compared to its average volume of 31,833. The company has a market capitalization of $160.08, a P/E ratio of 8.70 and a beta of 2.71. Fonar has a twelve month low of $17.20 and a twelve month high of $33.90.
Fonar (NASDAQ:FONR) last issued its quarterly earnings data on Thursday, November 9th. The medical equipment provider reported $0.54 earnings per share (EPS) for the quarter. Fonar had a net margin of 24.02% and a return on equity of 24.13%.
Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: Medical Equipment segment, and Physician Management and Diagnostic Services segment.
Receive News & Ratings for Fonar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fonar and related companies with MarketBeat.com's FREE daily email newsletter.